DoxorubicinTumour lysis syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1922卷 / 1期

关键词：

D O I：

10.1007/s40278-022-22523-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：238 / 238

相关论文

共 50 条

[1] DoxorubicinTumour lysis syndrome: case report
Reactions Weekly, 2013, 1482 (1) : 20 - 20
[2] DoxorubicinTumour lysis syndrome: case report
Reactions Weekly, 2023, 1979 (1) : 168 - 168
[3] DoxorubicinTumour lysis syndrome: case report
Reactions Weekly, 2020, 1793 (1) : 166 - 166
[4] Cisplatin/dacarbazine/doxorubicinTumour lysis syndrome: case report
Reactions Weekly, 2010, 1298 (1) : 13 - 13
[5] Cisplatin/cyclophosphamide/doxorubicinTumour lysis syndrome and myasthenia gravis : case report
Reactions Weekly, 2023, 1959 (1) : 195 - 195
[6] VenetoclaxTumour lysis syndrome: case report
Reactions Weekly, 2022, 1889 (1) : 314 - 314
[7] HydroxycarbamideTumour lysis syndrome: case report
Reactions Weekly, 2023, 1974 (1) : 170 - 170
[8] ImatinibTumour lysis syndrome: case report
Reactions Weekly, 2018, 1728 (1) : 184 - 184
[9] CisplatinTumour lysis syndrome: case report
Reactions Weekly, 2016, 1603 (1) : 67 - 67
[10] CarboplatinTumour lysis syndrome: case report
Reactions Weekly, 2019, 1740 (1) : 85 - 85

← 1 2 3 4 5 →